---
$id: https://graph.org.ai/products/commodity/51302306
$type: Product
source: UNSPSC
code: "51302306"
title: "Climbazole"
class: "51302300"
classTitle: "Antifungal imidazoles"
family: "51300000"
familyTitle: "Antifungal drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Climbazole

**UNSPSC Code**: 51302306
**Class**: [Antifungal imidazoles](Antifungal imidazoles.mdx)
**Family**: [Antifungal drugs](../Antifungal drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antifungal agent with the molecular formula C15H17ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9N42CW7I54, chemically known as 2-butanone, 1-(p-chlorophenoxy)-3,3-dimethyl-1-(1-imidazolyl)- but generally known as climbazole, which bears US NIH Compound Identifier 37907. European Medicines Agency schedules Climbazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06662MIG. The term CLIMBAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 32, No 10 1978, List 18). CLIMBAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule climbazole under HS 29332990 and SITC 51573. As of Q4 2014, CLIMBAZOLE remains the US FDA Preferred Term for this commodity. Climbazole bears US NLM identifiers UMLS ID C0666079 and NCI Concept Code C78033. SMILES: CLC1CCC(OC(N2CCNC2)C(=O)C(C)(C)C)CC1.

